Headlines Tagged with Investing — 4,032 headlines found
Despite a declining customer base and greater restrictions being placed on smoking in markets all around the globe, there is a convergence of events happening in 2018 that could make the year Philip Morris International's (NYSE:PM) best one yet.
Dec 9, 2017 Motley Fool
added Dec 15, 2017 03:04
British American Tobacco has declared a second interim dividend of 43.6p per ordinary share this year, to be paid in February as it makes a move to paying out returns on a quarterly basis. The dividend will be payable on 8 February to shareholders regist
Dec 5, 2017 Digital Look (uk)
added Dec 5, 2017 13:53
AUSTRALIA’S biggest superannuation fund is selling out of big tobacco... “We believe tobacco warrants special consideration due to its particular characteristics and the damage it causes,” Mr Silk said.
Dec 4, 2017 Melbourne (Vic) Herald Sun (au)
added Dec 4, 2017 15:06
After the original popularity of e-cigs, vapor devices suddenly gained traction and prepared to overwhelm the market. Lorillard was so worried about vaping devices that it wanted the FDA to ban them. But it may be the latest technological innovation that
Dec 3, 2017 Motley Fool
added Dec 4, 2017 15:59
With both Philip Morris International (PM) and Altria Group (MO) having posted their 3Q17 earnings, it’s time to compare them. In this series, we will look at 3Q17 revenues, margins, and EPS (earnings per share) of Philip Morris and Altria Group.
Dec 2, 2017 Market Realist
added Dec 2, 2017 16:26
The winner: British American Tobacco Altria is still a decent investment, but British American simply offers better growth opportunities across more markets, its earnings will be buoyed by a weaker pound for the foreseeable future, and it trades at a low
Nov 21, 2017 Motley Fool
added Nov 22, 2017 04:51
cancer immunotherapies, such as Merck's Keytruda...Another major cancer-immunotherapy player is Bristol-Myers Squibb with Opdivo and, to a lesser extent, Yervoy. ...A third company... is Swiss-based drug giant Roche
Nov 18, 2017 Motley Fool
added Nov 18, 2017 22:01
The group’s investment in BAT remains its single largest investment position, with the firm holding 68.1million shares in BAT, representing some 2.97percent of BAT’s issued share capital. The company said the decrease in its net asset value of 604millio
Nov 17, 2017 Independent Online (IOL) / The Post (za)
added Nov 17, 2017 21:37
Altria has a lot on its plate, but its financial strength remains secure. For investors, its future prospects include plenty of positives to go with the ever-present challenges that it has to overcome regularly.
Nov 15, 2017 Motley Fool
added Nov 15, 2017 15:31
For investors, the biggest question is how Philip Morris can navigate the [FDA] process for getting iQOS approved as a modified-risk tobacco product . The company's scientists see it as a step-by-step process: Product design is tailored to determine the
Nov 14, 2017 NASDAQ
added Nov 15, 2017 02:56